Skip to main content
Figure 4 | Journal of Experimental & Clinical Cancer Research

Figure 4

From: Are there candidates for high-dose chemotherapy in ovarian carcinoma?

Figure 4

Overall survival after conventional chemotherapy alone (black) or plus high dose chemotherapy (grey). (A) In patients under 50 years of age (n=52) median OS was 36 months in the CCA subset versus 54.6 months in the HDC subset; (B) in stage IIIc cases (n=129) median OS was 42 months in the CCA subset versus 49.5 months in the HDC subset; + censored data.

Back to article page